Botox®

BTXC-color

Are you ready to discover real, noticeable results?

Learn more about BOTOX® Cosmetic (onabotulinumtoxinA) and decide if it’s time to ask your doctor about treatment.

What is BOTOX® Cosmetic?

BOTOX® Cosmetic is the first and only FDA-approved product to temporarily improve both moderate to severe frown lines between the brows and crow’s feet lines around the sides of the eyes in adults.

How does BOTOX® Cosmetic work?

BOTOX® Cosmetic targets one of the underlying causes of frown lines and crow’s feet—the repeated muscle contractions from frowning and squinting over the years. Your doctor will inject these muscles with BOTOX® Cosmetic to temporarily reduce muscle activity. You’ll begin to notice a visible smoothing of these lines.

How is BOTOX® Cosmetic (onabotulinumtoxinA) administered?

To temporarily improve moderate to severe crow’s feet, your doctor will inject BOTOX® Cosmetic into the muscle surrounding the sides of your eyes—called the orbicularis oculi.

For temporary improvement of moderate to severe frown lines, BOTOX® Cosmetic is injected into 2 muscles—the corrugator and procerus muscles.

Treatment with BOTOX® Cosmetic takes approximately 10 minutes and requires minimal downtime or recovery—it’s often called a lunchtime procedure.

Think 2 treatments, 1 visit. Ask your doctor aboutreceiving BOTOX® Cosmetic for moderate to severe frown lines and crow’s feet at the same time.

Will BOTOX® Cosmetic make me look like I’ve had work done?

When BOTOX® Cosmetic is administered by an experienced injector, you should not lose the ability to show expressions. BOTOX® Cosmetic is a techniquesensitive procedure that should only be performed by a licensed and trained aesthetic provider who has expertise in facial anatomy.

Talk to your doctor about your expectations and the results you want to achieve with treatment.

 

Before & Afters

Actual patients. Results may vary.

botox-banda-1

Photos taken at maximum smile and at maximum frown before treatment with BOTOX® Cosmetic (onabotulinumtoxinA), and taken at maximum smile after treatment with BOTOX® Cosmetic at day 7, and taken at maximum frown after treatment with BOTOX® Cosmetic at day 7 and months 3 and 4.

Moderate to Severe Lateral Canthal Lines
In clinical trials at day 30, 26.1% (58/222) and 20.3% (62/306) of patients demonstrated a ≥ 2-grade improvement from baseline in crow’s feet line severity at maximum smile as compared to 1.3% (3/223) and 0% (0/306) for placebo, as assessed by both investigators and subjects.1

Moderate to Severe Glabellar Lines
In clinical trials at day 7, 74% (299/405) of patients demonstrated none or mild glabellar line severity at maximum frown as compared to 6% (8/132) in placebo, as assessed by investigators; at day 30, 80% (325/405) of patients demonstrated the same as compared to 3% (4/132) in placebo; at month 3, 48% (192/403) of patients demonstrated the same as compared to 2% (3/128) in placebo; at month 4, 25% (102/403) of patients demonstrated the same as compared to 2% (2/128) in placebo.1

In clinical trials at day 7, 82% (334/405) of patients achieved at least a moderate improvement in their glabellar line appearance compared to 9% (12/132) in placebo, as evaluated by patients; at day 30, 89% (362/405) of patients assessed the same as compared to 7% (9/132) in placebo; at month 3, 63% (254/403) of patients assessed the same as compared to 3% (4/128) in placebo; at month 4, 39% (157/403) of patients assessed the same as compared to 1% (1/128) in placebo.1

1. BOTOX® Cosmetic Prescribing Information, September 2013.